Ansana, an NLC venture, is on a mission to create and bring to the market an innovative technology for monitoring and verifying appropriate sterilization of medical devices and pharmaceutical products.
Every year 310 million surgeries are performed globally, requiring more than 1 billion sterile surgical instrument sets. This huge amount of procedures comes with many challenges from a patient risk, ecological and resource requirement perspective.
In the US and Europe alone, 1.3 million patients are affected yearly with Healthcare-Associated Infections (HAIs) linked with surgical instrument reprocessing. Only in the US, 115 million kg plastic waste is generated every year because of consumables in sterilization processes. Stricter infection control and medical safety regulations, combined with more complex surgical instruments, increase resource requirements significantly.
Asana’s unique and patented smart sterilisation container reduces surgical site infections, eliminates plastic consumables, while reducing total cost of ownership for hospitals. The innovative sterilisation container allows for environmental monitoring and measurement of critical process parameters inside the container through an electronic sensor module. This practically eliminates risk for process issues and makes the technology very suited for the increasingly complex instruments, such as endoscopes.
‘‘Ansana provides a unique system solution monitoring conditions in every step of the instrument reprocessing flow. Thus guaranteeing instrument sterility in the operating room, while providing full and real-time traceability.’’Dominique Surinx, CEO, Asana
Dominique combines 20 years of pharma experience in senior global positions, with successful entrepreneurial experience in renewable energy. He is committed to making a difference in patient safety and having an impact on the global ecology.